Upstream Bio, Inc.
UPB • XNAS
Upstream Bio, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO E. Rand Sutherland, with a market cap of $471.8M.
CEOE. Rand Sutherland
Next Earnings
Upcoming earnings announcement for Upstream Bio, Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.75
Revenue Estimate
$412.3K
Earnings History
Past 6 earnings reports for Upstream Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.78Est: -$0.71 | -9.9% | $668.0KEst: $600.9K | +11.2% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.63Est: -$0.78 | +19.2% | $683.0KEst: $694.1K | -1.6% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.74Est: -$0.61 | -21.3% | $937.0KEst: $458.2K | +104.5% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.51Est: -$0.54 | +5.6% | $566.0KEst: $352.8K | +60.5% | 10-Q |
| Mar 12, 2025 | Q4 2024 | -$0.48Est: -$0.48 | 0.0% | $613.0KEst: $326.3K | +87.9% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$6.96 | — | $607.0K | — | 10-Q |